Endo Fights In Fed. Circ. To Keep Opana Painkiller Patents
Endo Pharmaceuticals Inc. slammed a generic drugmaker's bid to invalidate portions of Endo's patents for the painkiller Opana ER in the Federal Circuit Monday, saying the Patent Trial and Appeal Board...To view the full article, register now.
Already a subscriber? Click here to view full article